Skip to main content
0 Nutrients Affected · Based on CTD Molecular Database

What Does Ciprofloxacin Deplete? 0 Nutrients Affected

Ciprofloxacin (Cipro) does not directly deplete nutrients, but it chelates essential minerals including magnesium, calcium, iron, and zinc in the gut, significantly reducing their absorption during treatment. The Comparative Toxicogenomics Database catalogs 97 gene interactions for ciprofloxacin, with 2,153 disease associations. While nutrient depletion from short courses is minimal, the mineral chelation and mitochondrial effects contribute to the tendon damage and neuropathy that carry an FDA black box warning.

Taking this medication? Check what it depletesFree, 10 seconds →

Data sourced from CTD, ChEMBL, FAERS, PubMed. How we verify this data →
Sources verified as of April 2026
[01]

Depletions Overview

Wondering about YOUR specific medications?

Check free — no signup, 10 seconds →
[02]

How It Causes Depletions

Ciprofloxacin is a fluoroquinolone antibiotic prescribed to approximately 12 million Americans annually under brand names Cipro and Cipro XR for urinary tract infections, respiratory infections, bone and joint infections, gastrointestinal infections, and anthrax prophylaxis. According to ChEMBL mechanism-of-action data, ciprofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV — enzymes essential for bacterial DNA replication. With oral bioavailability of 66%, peak plasma concentration reached within 0.81 hours, and an elimination half-life of 3.5 hours, ciprofloxacin is rapidly absorbed and typically prescribed for 7-14 day courses. While the short treatment duration means true nutrient depletion is uncommon, ciprofloxacin's powerful mineral chelation properties and mitochondrial effects create significant mineral absorption interference and tissue toxicity during active treatment.

The Comparative Toxicogenomics Database catalogs 97 gene interactions for ciprofloxacin, with 2,153 total disease associations and 202 curated disease links — one of the broadest molecular footprints of any antibiotic. Ciprofloxacin chelates divalent and trivalent metal ions including magnesium, calcium, iron, zinc, and aluminum, forming insoluble complexes in the gut that prevent absorption of both the mineral and the antibiotic. This chelation is bidirectional — minerals reduce ciprofloxacin absorption by 25-90% depending on the mineral and timing. Beyond chelation, fluoroquinolones directly damage mitochondria in human cells, particularly in tendons, cartilage, and peripheral nerves. Magnesium depletion is a contributing factor to fluoroquinolone-associated tendon damage because magnesium is critical for collagen synthesis, metalloproteinase regulation, and mitochondrial function in connective tissue.

PharmGKB pharmacogenomic annotations include 1 entry for ciprofloxacin, linking G6PD gene variants to hemolytic anemia toxicity. Across 175 randomized controlled trials involving 246,669 patients in ciprofloxacin research indexed by CTD, the fluoroquinolone class carries an FDA black box warning (2008, updated 2016 and 2018) for tendon rupture, peripheral neuropathy, and central nervous system effects collectively termed fluoroquinolone-associated disability (FQAD). Across 212 million rows in Kelda's database, ciprofloxacin is unique among medications on the platform because its primary nutritional concern is not depletion but chelation — the drug binds to minerals in the gut, reducing absorption of nutrients you are actively taking. This means mineral supplementation timing is critical: take magnesium, calcium, iron, and zinc supplements at least 2 hours before or 6 hours after each ciprofloxacin dose to avoid both reduced antibiotic effectiveness and reduced mineral absorption.

[03]

Symptoms to Watch For

Ciprofloxacin does not cause the gradual nutrient depletions seen with chronic medications, but its mineral chelation and mitochondrial toxicity effects can produce significant symptoms during and after short treatment courses. The FDA black box warning covers tendon damage, peripheral neuropathy, and CNS effects that may persist for months to years after completing the antibiotic. Patients already low in magnesium before starting ciprofloxacin are at highest risk for these adverse effects. Because fluoroquinolone-associated disability can emerge days to weeks after completing a course, ongoing self-monitoring for tendon pain, nerve symptoms, and mood changes is important even after the prescription bottle is empty.

[04]

What to Monitor

Request these at your next appointment. Check the ones you want to remember.

[05]

What vs Others

NameDepletionsPotencyNotes
CiprofloxacinThis drug0 nutrientsHighBroadest spectrum fluoroquinolone with 97 CTD gene interactions, strongest mineral chelation effect
Levofloxacin0 nutrientsHighSlightly fewer drug interactions than ciprofloxacin, same mineral chelation and FDA black box warnings
Moxifloxacin0 nutrientsHighBroadest gram-positive coverage, same chelation effects plus higher QT prolongation risk

All fluoroquinolones chelate minerals through the same divalent cation binding mechanism and carry identical FDA black box warnings for tendon rupture, peripheral neuropathy, and CNS effects. Ciprofloxacin has the broadest gram-negative coverage and strongest mineral chelation. Levofloxacin has slightly fewer drug interactions. Moxifloxacin adds gram-positive coverage but carries higher cardiac QT prolongation risk. According to CTD data, ciprofloxacin's 97 gene interactions represent the most extensively documented molecular profile in the fluoroquinolone class.

[06]

Food Sources for Depleted Nutrients

FoodAmount per Serving
Pumpkin seeds156mg per ounce — take 2+ hours before ciprofloxacin
Dark chocolate (70%+)65mg per ounce — take 2+ hours before ciprofloxacin
Almonds80mg per ounce — take 2+ hours before ciprofloxacin
Spinach (cooked)157mg per cup — take 2+ hours before ciprofloxacin
Avocado58mg per fruit — take 2+ hours before ciprofloxacin

Source: USDA Food Composition Database (658,209 food nutrient entries)

[07]

FAQ

[08]

References

  1. [1]Comparative Toxicogenomics Database (CTD): 97 ciprofloxacin gene interactions, 2,153 disease associations, 202 curated disease links (accessed April 2026)
  2. [2]ChEMBL Database: Ciprofloxacin classified as bacterial DNA gyrase inhibitor and topoisomerase IV inhibitor, Phase 4 indications for infections and urinary tract infections (accessed April 2026)
  3. [3]PharmGKB Database: 1 pharmacogenomic annotation for ciprofloxacin linking G6PD to hemolytic anemia toxicity (accessed April 2026)
  4. [4]PubMed: 6,000 indexed articles for ciprofloxacin; 175 randomized controlled trials across 246,669 patients (accessed April 2026)
  5. [5]FDA Drug Safety Communication: Black box warning for fluoroquinolones regarding tendon rupture, peripheral neuropathy, and CNS effects (2008, updated 2016, 2018)
  6. [6]FAERS Database: Adverse event reporting for ciprofloxacin including tendon rupture, peripheral neuropathy, and fluoroquinolone-associated disability (accessed April 2026)
  7. [7]Kelda Health Intelligence Platform: Cross-referenced analysis across 212 million rows integrating CTD, ChEMBL, FAERS, PharmGKB, and PubMed datasets (accessed April 2026)
This information is generated from peer-reviewed molecular databases including the Comparative Toxicogenomics Database (CTD), ChEMBL, and indexed PubMed research. It is not medical advice. Always consult your healthcare provider before making changes to your medications or supplements. See our methodology →

Check What YOUR Medications Deplete

Free. No signup. 10 seconds.

Check Now →